Details for New Drug Application (NDA): 212782
✉ Email this page to a colleague
The generic ingredient in BORTEZOMIB is bortezomib. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the bortezomib profile page.
Summary for 212782
Tradename: | BORTEZOMIB |
Applicant: | Shilpa |
Ingredient: | bortezomib |
Patents: | 0 |
Pharmacology for NDA: 212782
Mechanism of Action | Proteasome Inhibitors |
Medical Subject Heading (MeSH) Categories for 212782
Suppliers and Packaging for NDA: 212782
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BORTEZOMIB | bortezomib | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 212782 | NDA | Shilpa Medicare Limited | 63759-3032 | 63759-3032-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63759-3032-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE |
BORTEZOMIB | bortezomib | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 212782 | NDA | Amneal Pharmaceuticals LLC | 70121-2484 | 70121-2484-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-2484-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | Strength | 3.5MG/1.4ML (2.5MG/ML) | ||||
Approval Date: | Aug 26, 2024 | TE: | RLD: | Yes |
Complete Access Available with Subscription